Title:
ヒトホスホジエステラーゼ４Ｄバリアント７の発現に基づくリスクスコア
Document Type and Number:
Japanese Patent JP7184771
Kind Code:
B2
Abstract:
Methods are described for stratifying patient risk for patients with prostate cancer and for providing a treatment recommendation to a patient based on a phosphodiesterase 4D variant 7 (PDE4D7) risk score. A diagnostic kit and a computer program product for the analysis and determination of the PDE4D7 risk score are also described.
Inventors:
Ralph Hoffman
Fan Streipe, Diane Arnoldina Marhaleta Wilhelmina
Fan Brussels, Anne Hodefrida Catalina
Robel, Janek
Fan Zong, Johannes Baptiste Adrianus Dionysus
Den Biesen, Effeline Katharina Anna Cracina
Alves de Inda, Marcia
Fan Streipe, Diane Arnoldina Marhaleta Wilhelmina
Fan Brussels, Anne Hodefrida Catalina
Robel, Janek
Fan Zong, Johannes Baptiste Adrianus Dionysus
Den Biesen, Effeline Katharina Anna Cracina
Alves de Inda, Marcia
Application Number:
JP2019529487A
Publication Date:
December 06, 2022
Filing Date:
November 28, 2017
Export Citation:
Assignee:
Koninklijke Philips N.V.
International Classes:
C12Q1/6851; G01N33/53; G01N33/574
Domestic Patent References:
| JP2012526545A |
Other References:
Br. J. Cancer,2015年,Vol.113,pp.1502-1511
"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)", [online], 2016.5.26, [2021.9.24検索], インターネット
"このサイトについて", [online], 2016.9.9, [2021.9.24検索], インターネット
"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)", [online], 2016.5.26, [2021.9.24検索], インターネット
"このサイトについて", [online], 2016.9.9, [2021.9.24検索], インターネット
Attorney, Agent or Firm:
Tadashige Ito
Tadahiko Ito
Osamu Miyazaki
Tadahiko Ito
Osamu Miyazaki